Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis-Reference-Cited by-同舟云学术

Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis

Published:2006-03-07 Issue:5 Volume:144 Page:326
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Pignone Michael¹,Earnshaw Stephanie¹,Tice Jeffrey A.¹,Pletcher Mark J.¹

Affiliation:

1. From University of North Carolina and RTI–University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina; RTI Health Solutions, Research Triangle Park, North Carolina; and University of California, San Francisco, California.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of combined alpha-lipoic acid and mitoquinone supplementation on myocardial infarction in aged rats: Heart performance and molecular mechanisms;Experimental Gerontology;2024-05

2. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis;Health and Social Care Delivery Research;2024-02

3. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

4. MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis;RMD Open;2023-11

5. Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK;BMJ Open;2023-09